Steven Bandula

University College Hospital

Papers

1

Total Citations

21

H-Index

1

About

Dr. Steven Bandula is a leading interventional radiologist and researcher whose work centers on minimally invasive cancer treatments, with a particular focus on renal cell carcinoma and image-guided therapies. His major contributions lie in advancing nephron-sparing approaches for small renal masses, where he has pioneered high-level clinical evidence in a field historically lacking randomized controlled trials. His landmark 2023 study, the NEST trial, demonstrated the feasibility of a cohort-embedded RCT comparing percutaneous cryoablation to robot-assisted partial nephrectomy, addressing a critical gap in urologic oncology. This work, already garnering 21 citations, has significant implications for treatment decision-making and patient outcomes. Dr. Bandula’s research bridges interventional radiology and surgical oncology, emphasizing rigorous methodology to evaluate emerging technologies. His achievements include leading one of the few successful randomized trials in this challenging area, offering a model for future comparative effectiveness studies. For students and researchers, his work exemplifies how innovative trial design can overcome recruitment barriers in procedural specialties, ultimately guiding evidence-based, organ-preserving cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Nephron Sparing Treatment (NEST) for Small Renal Masses: A Feasibility Cohort-embedded Randomised Controlled Trial Comparing Percutaneous Cryoablation and Robot-assisted Partial Nephrectomy
21 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: University College Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago